Disease: Cancer, endometrial

KEYTRUDA

Pembrolizumab 25mg/mL; per vial; soln for IV infusion after dilution; preservative-free.

JEMPERLI

Dostarlimab-gxly 50mg/mL; per vial; soln for IV infusion after dilution.

LENVIMA

Lenvatinib 4mg, 10mg; caps.

DEPO-PROVERA

Medroxyprogesterone acetate 400mg/mL; susp for IM inj.